Insulin Syringes Market Expected to Reach 2,401.51 Million by 2030 | CAGR of 4.4%

Insulin syringes market was valued at $1,561.20 million in 2020, and is projected to reach $2,401.51 million by 2030, registering a CAGR of 4.4% from 2021 to 2030. An insulin syringe aids in delivering insulin to diabetic patients in required doses. The insulin syringes consist of three parts-a needles, a barrel, and a plunger, and is available in various sizes. The needle is usually thin and short and covered with a special material such as silicone in order to allow it to slide through the skin causing minimal pain. Barrel is the chamber that holds the insulin. It is marked with calibrations designed to show the units of insulin being injected. The plunger is the narrow rod that slides up and down the length of the barrel. it serves to either draw the insulin into the barrel or release the insulin from the barrel through the needle. Further, the size of the insulin syringe is selected based on the desired dosage of insulin to be administered to diabetic patients.

𝐋𝐢𝐬𝐭 𝐨𝐟 𝐊𝐞𝐲 𝐏𝐥𝐚𝐲𝐞𝐫𝐬 :

• Novo Nordisk A/S
• Biocon Ltd
• Abbott Laboratories
• Terumo Corporation
• Cardinal Health Inc
• Beckton and Dickinson Company
• Eli Lilly and Company
• Nipro Medical Corporation
• Medline Industries
• Hindustan syringe and medical device Ltd.

𝐃𝐨𝐰𝐧𝐥𝐨𝐚𝐝 𝐒𝐚𝐦𝐩𝐥𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 https://www.alliedmarketresearch.com/request-sample/3740

On the basis of syringe size, 3c/10 cc syringes(0.3ml) segment holds the largest share in market in 2020. The growth of the segment is attributable to the factors such as increase in use of 3/10cc syringes (0.3ml) due to rise in the prevalence of Type 1diabetes across the world are the key factor anticipating the growth of market.

On the basis of disease type, type 2 diabetes segment holds the largest share in market in 2020. The growth of the segment is attributable to the factors such as rise in the adoption of unhealthy lifestyles surge in prevalence of type diabetes across the world are the key factor anticipating the growth of market.

On the basis of end user, hospital & clinics segment holds the largest share in market in 2020 The growth of the segment is attributable to the factors such as rise in geriatric population and large patients pool and surge in prevalence type 2 diabetes across the world, which require the administration of insulin with the help of insulin syringes are the key factor anticipating the growth of market.

𝐅𝐨𝐫 𝐏𝐮𝐫𝐜𝐡𝐚𝐬𝐞 𝐈𝐧𝐪𝐮𝐢𝐫𝐲 https://www.alliedmarketresearch.com/purchase-enquiry/3740

North America acquired a major share of insulin syringes market in 2020 owing, high prevalence of diabetes, increase in healthcare expenditures and presence of key players of insulin syringe manufacturers. However, Asia-Pacific is expected to grow at the highest rate during the forecast period, owing to rise in diabetes prevalence in Asia- Pacific (coupled with large diabetic & pre-diabetic patient population), strengthening distribution networks of global product manufacturers in the region, &, continued expansion of advanced medical facilities in emerging countries (such as China & India) are the key factors anticipating the growth of market.

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Pawan Kumar, the CEO of Allied Market Research, is leading the organization toward providing high-quality data and insights. We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

Contact:

David Correa
5933 NE Win Sivers Drive
205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com